JP2012512863A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012512863A5 JP2012512863A5 JP2011541665A JP2011541665A JP2012512863A5 JP 2012512863 A5 JP2012512863 A5 JP 2012512863A5 JP 2011541665 A JP2011541665 A JP 2011541665A JP 2011541665 A JP2011541665 A JP 2011541665A JP 2012512863 A5 JP2012512863 A5 JP 2012512863A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- compound according
- hydrogen
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 12
- 150000003839 salts Chemical class 0.000 claims 11
- 239000011780 sodium chloride Substances 0.000 claims 11
- 229910052739 hydrogen Inorganic materials 0.000 claims 7
- 239000001257 hydrogen Substances 0.000 claims 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 5
- 125000001424 substituent group Chemical group 0.000 claims 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 2
- YZCKVEUIGOORGS-OUBTZVSYSA-N deuterium Chemical group [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims 2
- 229910052805 deuterium Inorganic materials 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 125000005842 heteroatoms Chemical group 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 150000002431 hydrogen Chemical group 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 1
- 125000003341 7 membered heterocyclic group Chemical group 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Claims (12)
- 式(I)の化合物または薬学的に許容できるその塩
R1は、ハロ、ヒドロキシ、(C1〜C6)アルコキシ、−NR7R8、−C(=O)NR7R8および3から7員の複素環からなる群から選択される1から3個の置換基で置換されている(C1〜C6)アルキルであり、ここで、R7およびR8は独立に、水素または(C1〜C6)アルキルであり、前記複素環は、O、NまたはSから独立に選択される1から3個のヘテロ原子を含有し、
R2は、水素またはメチルであり、
R3は、水素またはメチルであり、
R4は、水素、重水素またはFもしくはClから独立に選択される1から3個の置換基で置換されていてもよいメチルであり、
R5は、水素、重水素またはFもしくはClから独立に選択される1から3個の置換基で置換されていてもよいメチルであり、
R6は、Hまたは−C(=O)OHであり、
Xは、C(H)、C(F)、C(Cl)またはNである]。 - R2が水素であり、
R3が水素であり、
R4がメチルであり、
R5がメチルであり、
R6が−C(=O)OHであり、
XがC(H)である、請求項1または2に記載の化合物または薬学的に許容できるその塩。 - R1が、ハロ、ヒドロキシ、−NH2、−C(=O)NH2および3から7員の複素環からなる群から選択される1から3個の置換基で置換されている(C1〜C6)アルキルであり、ここで、前記複素環は、O、NまたはSから独立に選択される1から3個のヘテロ原子を含有する、請求項1から3のいずれかに記載の化合物または薬学的に許容できるその塩。
- 請求項1から10のいずれかに記載の化合物または薬学的に許容できるその塩と、薬学的に許容できる担体とを含む医薬組成物。
- 抗菌剤の製造における請求項1から10のいずれかに記載の化合物または薬学的に許容できる塩の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13915908P | 2008-12-19 | 2008-12-19 | |
US61/139,159 | 2008-12-19 | ||
PCT/IB2009/055544 WO2010070523A1 (en) | 2008-12-19 | 2009-12-07 | Monocarbams |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012512863A JP2012512863A (ja) | 2012-06-07 |
JP2012512863A5 true JP2012512863A5 (ja) | 2012-12-06 |
Family
ID=41727494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011541665A Pending JP2012512863A (ja) | 2008-12-19 | 2009-12-07 | モノカルバム |
Country Status (15)
Country | Link |
---|---|
US (2) | US8252782B2 (ja) |
EP (1) | EP2379546A1 (ja) |
JP (1) | JP2012512863A (ja) |
KR (1) | KR20110086742A (ja) |
CN (1) | CN102325769A (ja) |
AR (1) | AR074801A1 (ja) |
AU (1) | AU2009329169B2 (ja) |
CA (1) | CA2744756C (ja) |
IL (1) | IL213216A0 (ja) |
MX (1) | MX2011006541A (ja) |
PA (1) | PA8855001A1 (ja) |
SG (1) | SG171781A1 (ja) |
TW (1) | TW201026696A (ja) |
UY (1) | UY32336A (ja) |
WO (1) | WO2010070523A1 (ja) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2011006541A (es) * | 2008-12-19 | 2011-07-20 | Pfizer | Monocarbamas. |
SG190007A1 (en) | 2010-11-29 | 2013-06-28 | Pfizer | Monobactams |
UY34585A (es) * | 2012-01-24 | 2013-09-02 | Aicuris Gmbh & Co Kg | Compuestos b-lactámicos sustituidos con amidina, su preparación y uso |
EA202092620A1 (ru) * | 2015-09-23 | 2021-06-30 | Новартис Аг | Соли и твердые формы монобактамного антибиотика |
CN105481812B (zh) * | 2015-11-30 | 2020-04-21 | 重庆天奕恒化科技有限公司 | 一种5-苄氧基-4-氧代-4h-吡喃-2-羧酸的制备方法 |
AU2017339587A1 (en) | 2016-12-21 | 2019-07-04 | Aicuris Gmbh & Co. Kg | Combination therapy with amidine substituted ß-lactam compounds and ß-lactamase inhibitors for infections with antibiotic resistant bacterial strains |
CN111094281B (zh) | 2017-08-02 | 2023-08-29 | 诺华股份有限公司 | 用于制备单内酰胺抗生素的化学方法及其中间体 |
EP3672937A1 (en) | 2017-08-23 | 2020-07-01 | Helmholtz-Zentrum für Infektionsforschung GmbH | Novel cystobactamide derivatives |
AU2018325894B2 (en) | 2017-08-31 | 2022-08-04 | Hokko Chemical Industry Co., Ltd. | 1-(N,N-disubstituted carbamoyl) 4-(substituted sulfonyl)triazolin-5-one derivatives, 4-(N,N-disubstituted carbamoyl) 1-(substituted sulfonyl)triazolin-5-one derivatives, and herbicide containing same as active ingredient |
CN111511737B (zh) | 2018-01-29 | 2022-10-18 | 南京明德新药研发有限公司 | 用于治疗细菌感染的单环β-内酰胺化合物 |
EP4079305A4 (en) | 2019-12-19 | 2024-01-10 | Shenzhen Optimum Biological Tech Co Ltd | APPLICATION OF A COMPOUND IN THE PREPARATION OF DRUG |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4587047A (en) * | 1981-04-09 | 1986-05-06 | E. R. Squibb & Sons, Inc. | 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines |
NZ199981A (en) | 1981-04-09 | 1985-08-16 | Squibb & Sons Inc | 2-oxo-1-(((substituted sulphonyl)amino)carbonyl)azetidines |
US5006650A (en) * | 1987-02-11 | 1991-04-09 | The Upjohn Company | Novel N-1 substituted beta-lactams as antibiotics |
AU602067B2 (en) | 1987-02-11 | 1990-09-27 | Upjohn Company, The | Novel n-1 substituted beta-lactams as antibiotics |
EP0357604A1 (en) * | 1987-02-27 | 1990-03-14 | The Upjohn Company | Antibiotic beta-lactams containing a pyridone carboxylic acid or acid derivative |
CA1317298C (en) * | 1987-03-03 | 1993-05-04 | Upjohn Company (The) | Antibiotic sulfonylaminocarbonyl activated .beta.-lactams |
US4762922A (en) * | 1987-07-01 | 1988-08-09 | Squibb Corporation | 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines |
US5015737A (en) * | 1987-07-22 | 1991-05-14 | The Upjohn Company | Therapeutically useful beta-lactams |
US4777252A (en) * | 1987-08-13 | 1988-10-11 | E. R. Squibb & Sons, Inc. | 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines |
US4889930A (en) | 1987-12-21 | 1989-12-26 | E. R. Squibb & Sons, Inc. | Process for making 2-oxo-1-((substituted sulfonyl)amino)carbonzyl)azetidines and intermediates used therein |
JPH01305081A (ja) | 1988-04-04 | 1989-12-08 | E R Squibb & Sons Inc | 3―アシルアミノ―1―[[[(置換スルホニル)アミノ〕カルボニル〕アミノ〕―2―アゼチジノン類 |
EP0344707A3 (en) | 1988-06-02 | 1990-04-18 | E.R. Squibb & Sons, Inc. | 2-Oxo-1-[[(substituted sulfonyl)-amino]carbonyl]-azetidine derivatives |
US4959470A (en) * | 1988-08-17 | 1990-09-25 | E. R. Squibb & Sons, Inc. | 2-oxo-[[(substituted sulfonyl)-amino]carbonyl]-azetidines |
WO1990003376A1 (en) | 1988-09-27 | 1990-04-05 | The Upjohn Company | Dihydroxyaryl 4-substituted monocarbams as antibiotics |
CA2210787A1 (en) | 1997-07-17 | 1999-01-17 | William R. Collier | Self-contained work station |
CN101641095B (zh) | 2007-03-23 | 2012-10-31 | 巴斯利尔药物股份公司 | 用于治疗细菌感染的组合药物 |
MX2011006541A (es) * | 2008-12-19 | 2011-07-20 | Pfizer | Monocarbamas. |
-
2009
- 2009-12-07 MX MX2011006541A patent/MX2011006541A/es active IP Right Grant
- 2009-12-07 CN CN2009801569587A patent/CN102325769A/zh active Pending
- 2009-12-07 SG SG2011036704A patent/SG171781A1/en unknown
- 2009-12-07 CA CA2744756A patent/CA2744756C/en not_active Expired - Fee Related
- 2009-12-07 JP JP2011541665A patent/JP2012512863A/ja active Pending
- 2009-12-07 WO PCT/IB2009/055544 patent/WO2010070523A1/en active Application Filing
- 2009-12-07 AU AU2009329169A patent/AU2009329169B2/en not_active Ceased
- 2009-12-07 KR KR1020117013944A patent/KR20110086742A/ko active IP Right Grant
- 2009-12-07 EP EP09795553A patent/EP2379546A1/en not_active Withdrawn
- 2009-12-17 UY UY0001032336A patent/UY32336A/es not_active Application Discontinuation
- 2009-12-18 AR ARP090104977A patent/AR074801A1/es not_active Application Discontinuation
- 2009-12-18 US US12/641,343 patent/US8252782B2/en not_active Expired - Fee Related
- 2009-12-18 TW TW098143723A patent/TW201026696A/zh unknown
- 2009-12-18 PA PA20098855001A patent/PA8855001A1/es unknown
-
2011
- 2011-05-30 IL IL213216A patent/IL213216A0/en unknown
-
2012
- 2012-07-26 US US13/558,989 patent/US8324198B1/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2012512863A5 (ja) | ||
JP2013507423A5 (ja) | ||
PH12017501192B1 (en) | Certain amino-pyridazines, compositions thereof, and methods of their use | |
JP2011518833A5 (ja) | ||
MY162940A (en) | Quinoline derivative-containing pharmaceutical composition | |
JP2013537203A5 (ja) | ||
JP2010529147A5 (ja) | ||
JP2011037901A5 (ja) | ||
JP2007302689A5 (ja) | ||
JP2015500843A5 (ja) | ||
JP2013510120A5 (ja) | ||
JP2014525420A5 (ja) | ||
JP2010504286A5 (ja) | ||
PH12016502037A1 (en) | Certain amino-pyrimidines, compositions thereof, and methods for their use | |
MD20140084A2 (en) | New indolizine derivatives, method for preparing same and pharmaceutical compositions containing same | |
JP2009535307A5 (ja) | ||
CA2744756A1 (en) | Monocarbams and their use as antibacterial agent | |
JP2011105738A5 (ja) | ||
GB201201744D0 (en) | Novel compounds | |
JP2014507477A5 (ja) | ||
WO2008147557A3 (en) | Heteroaryl substituted thiazoles and their use as antiviral agents | |
JP2014516033A5 (ja) | ||
MX2008016558A (es) | Preparacion y aplicacion terapéutica de derivados de 2-benzoil-imidazopiridinas. | |
EA201270099A1 (ru) | Транс-4-[[(5s)-5-[[[3,5-бис(трифторметил)фенил]метил](2-метил-2h-тетразол-5-ил)амино]-2,3,4,5-тетрагидро-7,9-диметил-1h-1-бензазепин-1-ил]метил]циклогексанкарбоновая кислота | |
JP2013544854A5 (ja) |